Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma

Figure 3

Construction of a prognostic model based on three key gene. (a) LASSO coefficient profiles of the three key genes. (b) Plots of the ten-fold cross-validation error rates. (c) Distribution of risk score, survival status, and the expression of three prognostic genes in BLCA. (d) Overall survival curves for BLCA patients in the high-/low-risk group. (e) ROC analysis was performed to measure the predictive value. BLCA: bladder urothelial carcinoma; LASSO: least absolute shrinkage and selection operator; ROC: receiver operating characteristic curve; HR: hazard ratio; CI: confidence interval.

(a)

(b)

(c)

(d)

(e)